Methicillin-Resistant Staphylococcus Aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
It is hoped that an increase in serious hospital-acquired infections such as MRSA will be combatted by the new and improved drug treatment options in the pipeline due for launch in the near future, according to pharmaceutical experts GlobalData.
View full press release